IP6K2 is a client for HSP90 and a target for cancer therapeutics development

David S. Shames, John D. Minna

Research output: Contribution to journalComment/debatepeer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'IP6K2 is a client for HSP90 and a target for cancer therapeutics development'. Together they form a unique fingerprint.